Role of miR-34c in ketamine-induced neurotoxicity in neonatal mice hippocampus

Cell Biology International

Volumn 39, Issue 2, 2015, Pages 164-168

  Cao, Shu e ^a   Tian, Jianmin ^a   Chen, Shengyang ^a   Zhang, Xiaoran ^a   Zhang, Yongqiang ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Hippocampus; Ketamine; miR 34c; Neurotoxicity

Indexed keywords

KETAMINE; MICRORNA; MICRORNA 34C; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE C; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MOLECULAR PATHOLOGY; MORRIS WATER MAZE TEST; MOUSE; NEUROTOXICITY; NEWBORN; NONHUMAN; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DOWN REGULATION; DRUG EFFECTS; MAZE TEST; METABOLISM; UPREGULATION;

MUS;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; KETAMINE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 84921497056     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10349     Document Type: Article

References (24)

1. Agostini M, Tucci P, Killick R, Candi E, Sayan BS, di val Cervoval PR, et al. (2011) Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci 108: 21093-8.
2. Brambrink AM, Orfanakis A, Kirsch JR (2012) Anesthetic neurotoxicity. Anesthesiol Clin 30: 207-28.
3. Casci T, (2012) Ageing: MicroRNA tunes ageing pathway in flies. Nat Rev Genet 13: 222-3.
4. Darnell DK, Kaur S, Stanislaw S, Konieczka JH, Yatskievych TA, Antin PB (2006) MicroRNA expression during chick embryo development. Dev Dyn 235: 3156-65.
5. Domino EF (2010) Taming the ketamine tiger. 1965. Anesthesiology 113: 678-84.
6. Dong C, Anand K (2013) Developmental neurotoxicity of ketamine in pediatric clinical use. Toxicol Lett.
7. Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R, et al. (2011) MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci 31: 14191-203.
8. Hayashi H, Dikkes P, Soriano SG (2002) Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 12: 770-4.
9. Huang L, Liu Y, Jin W, Ji X, Dong Z (2012) Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCgamma-ERK signaling pathway in the developing brain. Brain Res 1476: 164-71.
10. Huang L, Liu Y, Zhang P, Kang R, Li X, Bo L, et al. (2013) In vitro dose-dependent inhibition of the intracellular spontaneous calcium oscillations in developing hippocampal neurons by ketamine. PLoS One 8: e59804.
11. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, et al. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-4.
12. Juhila J, Sipila T, Icay K, Nicorici D, Ellonen P, Kallio A, et al. (2011) MicroRNA expression profiling reveals miRNA families regulating specific biological pathways in mouse frontal cortex and hippocampus. PLoS One 6: e21495.
13. Kim VN (2005) Small RNAs: classification biogenesis, and function. Mol Cells 19: 1-15.
14. Kosik KS (2006) The neuronal microRNA system. Nat Rev Neurosci 7: 911-20.
15. Kosik KS, Krichevsky AM (2005) The elegance of the MicroRNAs: a neuronal perspective. Neuron 47: 779-82.
16. Lau P, Hudson LD (2010) MicroRNAs in neural cell differentiation. Brain Res 1338: 14-9.
17. Liu N, Landreh M, Cao K, Abe M, Hendriks G-J, Kennerdell JR, et al. (2012) The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482: 519-23.
18. McGowan FX, Jr., Davis PJ (2008) Anesthetic-related neurotoxicity in the developing infant: of mice, rats, monkeys and, possibly, humans. Anesth Analg 106: 1599-602.
19. Olney J, Labruyere J, Wang G, Wozniak D, Price M, Sesma M (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science (Washington) 254: 1515-8.
20. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S-i, et al. (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFOE R B activation in primary hippocampal neurons. J Biol Chem 274: 8531-8.
21. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, et al. (2009) MiR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 80: 268-73.
22. Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, et al. (2012) MicroRNA 34c gene down-regulation via DNA methylation promotes selfrenewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem 287: 465-73.
23. Zhao L, Wu T-w, Brinton RD (2004) Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 1010: 22-34.
24. Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, et al. (2011) MicroRNA-34c is a novel target to treat dementias. Embo J 30: 4299-308.